Attempts to eradicate tuberculosis are stymied by the fact that the disease-causing bacteria have a sophisticated mechanism for surviving dormant in infected cells. Now, a team of scientists has identified compounds that inhibit that mechanism — without damaging human cells — which could lead to the design of new anti-TB drugs.